About the NDA filing.
D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019258:Saquinavir / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D019258:Saquinavir